Youping Deng to Lung Neoplasms
This is a "connection" page, showing publications Youping Deng has written about Lung Neoplasms.
Connection Strength
2.485
-
Gao Z, Nasu M, Devendra G, Abdul-Ghani AA, Herrera AJ, Borgia JA, Seder CW, Kuehu DL, Feng Z, Chen Y, Gong T, Zhang Z, Chan O, Yang H, Yu J, Fu Y, Wu L, Deng Y. A robust machine learning model based on ribosomal-subunit-derived piRNAs for diagnostic potential of nonsmall cell lung cancer across multicentre, large-scale of sequencing data. Clin Transl Med. 2025 Aug; 15(8):e70418.
Score: 0.620
-
Chen S, Liu F, Fu Y, Deng CK, Borgia JA, Ayman AG, Nasu M, Jijiwa M, Yang H, Gong T, Wang J, Ling Z, Wang X, Wang H, Chu Q, Deng Y. A prospective multi-cohort study identifies and validates a 5-gene peripheral blood signature predictive of immunotherapy response in non-small cell lung cancer. Mol Cancer. 2024 Nov 06; 23(1):247.
Score: 0.589
-
Chen Y, Zitello E, Guo R, Deng Y. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer. Clin Transl Med. 2021 04; 11(4):e367.
Score: 0.459
-
Zhao T, Khadka VS, Deng Y. Identification of lncRNA biomarkers for lung cancer through integrative cross-platform data analyses. Aging (Albany NY). 2020 07 16; 12(14):14506-14527.
Score: 0.437
-
Dou Y, Zhu Y, Ai J, Chen H, Liu H, Borgia JA, Li X, Yang F, Jiang B, Wang J, Deng Y. Plasma small ncRNA pair panels as novel biomarkers for early-stage lung adenocarcinoma screening. BMC Genomics. 2018 Jul 20; 19(1):545.
Score: 0.381